Extendicare (TSE:EXE) Announces Earnings Results

Extendicare (TSE:EXE) posted its quarterly earnings data on Thursday. The company reported C$0.32 earnings per share for the quarter, FiscalAI reports. The business had revenue of C$611.04 million during the quarter. Extendicare had a return on equity of 45.35% and a net margin of 6.99%.

Extendicare Stock Down 5.1%

TSE:EXE traded down C$1.75 on Friday, hitting C$32.44. The stock had a trading volume of 1,523,180 shares, compared to its average volume of 388,521. The company has a quick ratio of 0.98, a current ratio of 1.44 and a debt-to-equity ratio of 82.55. Extendicare has a 52 week low of C$12.64 and a 52 week high of C$39.14. The business’s fifty day moving average is C$35.24 and its 200 day moving average is C$30.19. The company has a market cap of C$3.08 billion, a PE ratio of 23.87 and a beta of 1.59.

Extendicare Announces Dividend

The company also recently declared a monthly dividend, which will be paid on Monday, August 17th. Shareholders of record on Monday, August 17th will be issued a $0.0441 dividend. The ex-dividend date is Friday, July 31st. This represents a c) annualized dividend and a yield of 1.6%. Extendicare’s dividend payout ratio is presently 37.24%.

Analyst Upgrades and Downgrades

EXE has been the subject of several recent research reports. TD increased their price target on Extendicare from C$32.00 to C$39.00 and gave the company a “buy” rating in a research note on Monday, May 11th. Canaccord Genuity Group upgraded Extendicare to a “strong-buy” rating in a research report on Monday, May 11th. National Bank Financial raised their target price on Extendicare from C$34.00 to C$40.00 and gave the stock an “outperform” rating in a research note on Wednesday, May 27th. BMO Capital Markets lifted their target price on Extendicare from C$30.00 to C$38.00 in a report on Wednesday, May 13th. Finally, Desjardins set a C$34.50 price target on Extendicare and gave the stock a “buy” rating in a report on Wednesday, April 22nd. Two analysts have rated the stock with a Strong Buy rating and six have given a Buy rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Buy” and an average price target of C$32.56.

Extendicare Company Profile

Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.